Literature DB >> 30407243

Updated Imaging Features of Dysplastic Cerebellar Gangliocytoma.

Radhika Dhamija, Christopher P Wood1, Alyx B Porter2, Leland S Hu3, Steven M Weindling4, Joseph M Hoxworth3.   

Abstract

OBJECTIVE: The aim of this study was to perform an updated review of the imaging features of dysplastic cerebellar gangliocytoma (DCG).
METHODS: Imaging findings were retrospectively reviewed in 14 patients with DCG. The analysis included size, location, cyst formation, calcification, intralesional hemorrhage, enhancement pattern, and apparent diffusion coefficient (ADC).
RESULTS: In addition to revisiting many well-established imaging features of DCG, enhancement was much more common (64.3%) than previously reported, and small enhancing veins were also frequently encountered within or along the periphery of the lesions (50%). Dysplastic cerebellar gangliocytomas had an elevated ADC compared with normal cerebellum (967.8 ± 115.7 vs 770.4 ± 47.3 × 10 mm/s; P < 0.0001).
CONCLUSIONS: Enhancement on magnetic resonance imaging within DCG should be an accepted imaging finding rather than being viewed as uncommon or atypical. Dysplastic cerebellar gangliocytomas typically have an elevated ADC compared with normal cerebellum, which may assist in differentiation from other posterior fossa neoplasms.

Entities:  

Mesh:

Year:  2019        PMID: 30407243     DOI: 10.1097/RCT.0000000000000814

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

1.  The surgical resection of dysplastic cerebellar gangliocytoma assisted by intraoperative sonography: illustrative case.

Authors:  Yiming Li; Jiahe Guo; Huijie Wei; Cuiyun Sun; Yan Chai; Xiuwei Fu; Kai Zhang; Shengping Yu; Xuejun Yang
Journal:  J Neurosurg Case Lessons       Date:  2021-10-04

Review 2.  MR imaging features of Lhermitte-Duclos disease: Case reports and literature review.

Authors:  Han-Wen Zhang; Yuan-Qing Zhang; Xiao-Lei Liu; Yong-Qian Mo; Yi Lei; Fan Lin; Yu-Ning Feng
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.